Skip to main content

PUBLIC COMMENTS CLOSE AUGUST 7, 2026 AT 11:59 P.M. ET

Save Tianeptine

Stories

Lived experience helps decision-makers understand why research access matters. Your story is never published automatically — a person reviews every submission, removes anything risky, and publishes only with your consent.

The deadline is August 7, 2026 — comment first

The single most valuable place for your experience right now is the official federal docket. A story here supports the campaign; a comment there becomes part of the record the agency must consider.

Build my public comment

Share your story

Never published. Used only to reach you about your story.

Do not include vendor names, sourcing information, purchasing details, dosing instructions, current possession, or anything you do not want posted publicly.

Consent & safety

Voices for research access

Reviewed stories will be published here. Nothing appears on this page until a person has read it, removed anything risky, and confirmed consent with the author.

Federal regulatory comments are generally public. Do not include information you do not want publicly displayed. This website does not provide medical or legal advice.